This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
The New England journal of medicine, 391(4), 299-310
Citation
Loomba, Rohit; Hartman, Mark L; Lawitz, Eric J; Vuppalanchi, Raj; Boursier, Jérôme; Bugianesi, Elisabetta; Yoneda, Masato; Behling, Cynthia; Cummings, Oscar W; Tang, Yuanyuan; Brouwers, Bram; Robins, Deborah A; Nikooie, Amir; Bunck, Mathijs C; Haupt, Axel; Sanyal, Arun J. (2024). Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.. The New England journal of medicine, 391(4), 299-310. https://doi.org/10.1056/NEJMoa2401943